(Reuters) -Infant hospitalizations due to respiratory syncytial virus (RSV) infections in the United States dropped as much ...

The American Association for Cancer Research has called on Congress "to summarily reject" the Trump administration's 2026 ...

Use of the investigational drug efruxifermin did not significantly reduce fibrosis in patients with compensated cirrhosis ...

Calquence (acalabrutinib) plus bendamustine and rituximab reduced risk for disease progression or death by 27% compared with ...

In the POTOMAC study, one year of treatment with Imfinzi (durvalumab) plus standard-of-care BCG induction and maintenance ...

Professional analysts at Barclays Capital have reiterated their Buy ratings on these proven UK shares, so should investors ...

Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for ...

Durvalumab plus full BCG significantly improved disease-free survival in high-risk early bladder cancer vs BCG alone in the ...

Bernstein analysts estimate that if a 20% tariff were applied to the cost of goods sold for U.S. sales, the impact on earnings would range from low- to high-single digits for major European drugmakers ...

U.K. trade deal came in an email from the White House on pharmaceuticals. The upshot -- once the U.S. comes up with tariffs on pharmaceuticals, the U.K. drug industry will quickly get lowered rates.

PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced the appointment of Dr. Karen Smith, MD, PhD, MBA, ...

Michael Hakes, senior portfolio manager at Murray Wealth Group, discusses his past stock picks and how they're doing in the ...